Behçet's disease

Textbook of Pediatric Rheumatology

Volumn , Issue , 2005, Pages 561-566

  Ozen, Seza ^a   Petty, Ross E ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947604878     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-0246-8.50033-4     Document Type: Chapter

References (88)

1. Behçet H Über rezidivierende Aphthöse, durch ein Virus verusachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 1937, 105:1151-1157.
2. Adamantiades B Le thrombophlébite comme quatriéme symptome de l'iritis récidivante à hypopyon. Ann Ocul (Paris) 1946, 179:143-148.
3. Matteson EL Notes on the history of eponymic idiopathic vasculitis: the diseases of Henoch and Schönlein, Wegener, Churg and Strauss, Horton, Takayasu, Behçet, and Kawasaki. Arthritis Clin Res 2000, 13:237-245.
4. Kaklamani VG, Vaiopoulos G, Kaklamanis PG Behçet's disease. Semin Arthritis Rheum 1998, 27:197-217.
5. International Study Group for Behçet's Disease Criteria for diagnosis of Behçet's disease. Lancet 1990, 335:1070-1080.
6. Mason RM, Barnes CGL Behçet's syndrome with arthritis. Ann Rheum Dis 1969, 28:95-103.
7. O'Duffy JD, Goldstein NP Neurologic involvement in seven patients with Behçet's disease. Am J Med 1976, 61:170-178.
8. Rigby AS, Chamberlain MA, Bhakta B Classification and assessment of rheumatic diseases. Part I. Behçet's disease. Baillieres Clin Rheumatol 1995, 9:375-395.
9. Dilsen N History and development of Behçet's disease. Rev Rhum (Engl Ed) 1996, 63:512-519.
10. Sen DK Endogenous uveitis in Indian children: analysis of 94 cases. J Pediatr Ophthalmol 1977, 14:25-32.
11. Koné-Paut I, Bernard JL La maladie de Behçet chez l'enfant en France. Arch Fr Pediatr 1993, 50:561-565.
12. Koné-Paut I, Yurdakul S, Bahabri SA, et al. Epidemiological features of Behçet's syndrome in children: an international collaborative survey of 86 cases. J Pediatr 1998, 132:721-725.
13. Ozen S, Karaaslan Y, Ozdemir O, et al. Prevalence of juvenile chronic arthritis and Familial Mediterranean Fever in Turkey. A field study. J Rheumatol 1998, 25:2445-2449.
14. Lang BA, Laxer RM, Thorner P, et al. Pediatric onset of Behçet's syndrome with myositis: case report and literature review illustrating unusual features. Arthritis Rheum 1990, 33:418-425.
15. Vaiopoulos G, Kaklamani VG, Markomichelakis N, et al. Clinical features of juvenile Adamantiades-Behçet's disease in Greece. Clin Exp Rheumatol 1999, 17:256-259.
16. Bahabri SA, Al-Mazyed A, Al-Balaa S, et al. Juvenile Behçet's disease in Arab children. Clin Exp Rheumatol 1996, 14:331-335.
17. Eldem B, Onur C, Ozen S Clinical features of pediatric Behçet's disease. J Pediatr Ophthalmol Strabismus 1998, 35:159-161.
18. Kim DK, Chang SN, Bang D, et al. Clinical analysis of 40 cases of childhood-onset Behçet's disease. Pediatr Dermatol 1994, 11:95-101.
19. Pivetti-Pezzi P, Accorinti M, Abdulaziz MA, et al. Behçet's disease in children. Jpn J Ophthalmol 1995, 39:309-314.
20. Fujikawa S, Suemitsu T Behçet disease in children: a nationwide retrospective survey in Japan. Acta Paediatr Jpn 1997, 39:285-289.
21. Uziel Y, Brik R, Padeh S, et al. Juvenile Behçet's disease in Israel. Clin Exp Rheumatol 1998, 16:502-505.
22. Sarica R, Azizlerli G, Kose A, et al. Juvenile Behçet's disease among 1784 Turkish Behçet's patients. Int J Dermatol 1996, 35:109-111.
23. Stark AC, Bhakta B, Chamberlain MA, et al. Life-threatening transient neonatal Behçet's disease. Br J Rheumatol 1997, 36:700-702.
24. Fam AG, Siminovitch KA, Carette S, From L Neonatal Behçet's syndrome in an infant of a mother with the disease. Ann Rheum Dis 1981, 40:509-512.
25. Lewis MA, Priestly BL Transient neonatal Behçet's disease. Arch Dis Child 1986, 61:805-806.
26. Gül A, Insanü M, Öcal L, et al. Familial aggregation of Behçet's disease in Turkey. Ann Rheum Dis 2000, 59:622-625.
27. Koné-Paut I, Geisler I, Wechsler B, et al. Familial aggregation in Behçet's disease. J Pediatr 1999, 135:89-93.
28. Chajek-Shaul T, Pisanty S, Knobler H, et al. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome. Am J Med 1987, 83:666-672.
29. Mizuki N, Ota M, Yabuki K, et al. Localization of the pathogenic gene of Behçet's Disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci 2000, 41:3702-3708.
30. Wallace GR, Verity DH, Delamaine LJ, et al. MIC-A allele profiles and HLA class 1 associations in Behçet's disease. Immunogenetics 1999, 49:613-617.
31. Verity DH, Wallace GR, Vaughan RW, Stanford MR Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol 2003, 87:1175-1183.
32. Lehner T The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease. Int Rev Immunol 1997, 14:21-32.
33. Hasan A, Fortune F, Wilson A, et al. Role of gamma delta T cells in pathogenesis and diagnosis of Behçet's disease. Role of gamma delta T cells in pathogenesis and diagnosis of Behçet's disease. Lancet 1996, 347:1631-1632.
34. Yazici H, Tuzun Y, Pazarli H, et al. The combined used of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey. J Rheumatol 1980, 7:206-210.
35. Mamo JG The rate of visual loss in Behçet's disease. Arch Ophthalmol 1970, 84:451-452.
36. Yazici H, Yurdakul S, Hamuryudan V Behçet's syndrome. Curr Opin Rheumatol 2001, 13:18-22.
37. Koné-Paut I, Chabrol B, Riss JM, et al. Neurologic onset of Behçet's disease: a diagnostic enigma in childhood. J Child Neurol 1997, 12:237-241.
38. O'Duffy JD, Goldstein NP Neurologic involvement in seven patients with Behçet's disease. Am J Med 1976, 61:170-178.
39. Chamberlain MA, Robertson RJ A controlled study of sacroiliitis in Behçet's disease. Br J Rheumatol 1993, 32:693-698.
40. Sarui H, Maruyama T, Ito I, et al. Necrotising myositis in Behçet's disease: characteristic features on magnetic resonance imaging and a review of the literature. Ann Rheum Dis 2002, 61:751-752.
41. Enoch BA, Castillo-Olivares JL, Khoo TCL, et al. Major vascular complications in Behçet's syndrome. Postgrad Med J 1968, 44:453-459.
42. Davies JD Behçet's syndrome with haemoptysis and pulmonary lesions. J Pathol 1973, 109:351-356.
43. Grenier P, Bletry O, Cornud F, et al. Pulmonary involvement in Behçet's disease. Am J Roentgenol 1981, 137:565-569.
44. Erkan F Pulmonary involvement in Behçet disease. Curr Opin Pulm Med 1999, 5:314-318.
45. Agdad Kose A, Kayabali M, et al. Pulmonary artery involvement in Behçet's disease. Adv Exp Med Biol 2003, 528:419-422.
46. Vaiopoulos G, Pangratis N, Samarkos M, et al. Nailfold capillary abnormalities in Behçet's disease. J Rheumatol 1995, 22:1108-1111.
47. Shimizu T, Ehrlich GE, Inaba G, Hayashi K Behçet's disease (Behçet's syndrome). Semin Arthritis Rheum 1979, 8:223-260.
48. Bayraktar Y, Ozaslan E, van Thiel DH Gastrointestinal manifestation of Behçet's disease. J Clin Gastroenterol 2000, 30:144-154.
49. Akpolat T, Akkoyunlu M, Akpolat I, et al. Renal Behçet's disease: a cumulative analysis. Semin Arthritis Rheum 2002, 31:317-337.
50. Gürgün C, Ercan E, Ceyhun C, et al. Cardiovascular involvement in Behçet's disease. Jpn Heart J 2002, 43:389-399.
51. Erkan F, Gül A, Tasali E Pulmonary manifestations of Behçet disease. Thorax 2001, 56:572-578.
52. Arkin CR, Rothschild BM, Florendo NT, Popoff N Behçet syndrome with myositis: a case report with pathologic findings. Arthritis Rheum 1980, 23:600-604.
53. Ergun T, Gurbuz O, Harvell J, et al. The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behçet's disease. Int J Dermatol 1998, 37:929-933.
54. Jorizzo JL, Soloman AR, Cavallo T Behçet's syndrome: immunopathological and histopathological assessment of pathergy lesions is useful in diagnosis and follow-up. Arch Pathol Lab Med 1985, 109:747-751.
55. Scully C, Boyle P, Yap PL Immunoglobulins G, M, A, D, and E in Behçet's syndrome. Cloin Chim Acta 1982, 120:237-242.
56. Klok AM, de Vries J, Rothova A, et al. Antibodies against ocular and oral antigens in Behçet's disease associated with uveitis. Curr Eye Res 1989, 8:957-962.
57. Vaiopoulos G, Hatzinicolaou P, Tsiroyanni A, et al. Antineutrophil cytoplasmic antibodies in Adamantiades-Behçet's disease. Br J Rheumatol 1994, 33:406-407.
58. Tokay S, Direskeneli H, Yurdakul S, Akoglu T Anticardiolipin antibodies in Behçet's disease: a reassessment. Rheumatology (Oxf) 2001, 40:192-195.
59. Demirer S, Sengül N, Yerdel MA, et al. Haemostasis in patients with Behçet's disease. Eur J Vasc Endovasc Surg 2000, 19:570-574.
60. Sayinalp N, Ozcebe OI, Ozdemir O, et al. Cytokines in Behçet's disease. J Rheumatol 1996, 23:321-322.
61. Turan B, Gallati H, Erdi H, et al. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet's disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 1997, 24:128-132.
62. Al-Dalaan A, Al-Sedairy S, Al-Balaa S, et al. Enhanced interleukin 8 secretion in circulation of patients with Behçet's disease. J Rheumatol 1995, 22:904-907.
63. Carletto A, Pacor ML, Biasi D, et al. Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behçet's disease. J Rheumatol 1997, 24:1332-1336.
64. Takeno M, Kariyone A, Yamashita N, et al. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995, 38:426-433.
65. Yurdakul S, Yazici H, Tuzun Y, et al. The arthritis of Behçet's disease: a prospective study. Ann Rheum Dis 1983, 42:505-515.
66. Akpolat T, Danaci M, Belet U, et al. MR imaging and MR angiography in vascular Behçet's disease. Magn Reson Imaging 2000, 18:1089-1096.
67. Akman-Demir G, Bahar S, Coban O, et al. Cranial MRI in Behçet's disease: 134 examinations of 98 patients. Neuroradiology 2003, 45:851-859.
68. Nobili F, Cutolo M, Sulli A, et al. Brain functional involvement by perfusion SPECT in systemic sclerosis and Behçet's disease. Ann N Y Acad Sci 2002, 966:409-414.
69. Ozen S The spectrum of vasculitis in children. Baillieres Best Pract Res Clin Rheumatol 2002, 16:411-425.
70. Kari JA, Shah V, Dillon MJ Behçet's disease in UK children: clinical features and treatment including thalidomide. Rheumatology 2001, 40:933-938.
71. Sharquie KE, Najim RA, Abu-Raghif AR Dapsone in Behçet's disease: a double blind placebo controlled cross over study. J Dermatol 2002, 29:267-279.
72. Yurdakul S, Mat C, Tüzün Y, et al. A double-blind trial of colchicine in Behçet's syndrome. Arthritis Rheum 2001, 44:2686-2692.
73. Saenz A, Ausejo M, Shea B, et al. Pharmacotherapy for Behçet's Syndrome. Cochrane Database Syst Rev 2004, 2. CD001084.
74. Yazici H, Pazarli H, Barnes GG, et al. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990, 322:281-285.
75. Whitcup SM, Salvo EC, Nussenblatt RB Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease. Am J Ophthalmol 1994, 118:39-45.
76. Pacor ML, Biasi D, Lunardi C, et al. Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapy. Clin Rheumatol 1994, 13:224-227.
77. Schirmer M, Calamia KT, Direskeneli H International conference on Behçet's disease. Seoul, Korea, 2000. J Rheumatol 2000, 28:636-639.
78. Sfikakis PP Behçet's disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 2002, 61(Suppl 2):ii51-ii53.
79. Yazici H, Yurdakul S, Hamuryudan V Behçet's syndrome. Oxford Textbook of Rheumatology 1998, 1394-1402. Oxford University Press, Oxford. 2nd ed. P.J. Maddison, D.A. Isenberg, P. Woo, D.N. Class (Eds.).
80. Hirohata S, Suda H, Hashimoto T Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behçet's disease. J Neurol Sci 1998, 159:181-185.
81. Rakover Y, Adar H, Tal I, et al. Behçet disease: long-term followup of three children and review of the literature. Pediatrics 1989, 83:986-992.
82. Matteson EL, O'Duffy JD Treatment of Behçet's disease with chlorambucil. Behçet's Disease: Basic and Clinical Aspects. Proceedings of the Fifth International Conference on Behçet's Disease 1992, 575. Marcel Dekker, New York. J.D. O'Duffy, E. Kokmen (Eds.).
83. Tessler HH, Jennings T High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease. Br J Ophthalmol 1990, 74:353-357.
84. Hamuryudan V, Mat C, Saip S, et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998, 128:443-450.
85. Sakane T, Takeno M Novel approaches to Behçet's disease. Expert Opin Invest Drugs 2000, 9:1993-2005.
86. Mundy TM, Miller JJ III Behçet's disease presenting as chronic aphthous stomatitis in a child. Pediatrics 1978, 62:205-208.
87. Ammann AJ, Johnson A, Fyfe GA, et al. Behçet syndrome. J Pediatr 1985, 107:41-43.
88. O'Duffy JD Prognosis in Behçet's syndrome. Bull Rheum Dis 1978, 29:972.